Tabula Rasa HealthCare Reports First Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Wells Fargo names 13 stocks as overweight tactical ideas
- Twilio, Vylor set to join S&P 500 as index reshuffles members
Tabula Rasa HealthCare (TRHC) Misses Q1 EPS by 1c, Revenues Beat; Offers 2Q Revenue Guidance Below Consensus, Maintains FY20 Revenues Mid-Point Guidance Above Consensus
May 7, 2020 5:15 PM EDTTabula Rasa HealthCare (NASDAQ: TRHC) reported Q1 EPS of ($0.01), $0.01 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $72.8 million versus the consensus estimate of $71.64 million.
First Quarter 2020 Highlights
Total revenue of $72.8 million, near the high end of our guidance range of $68.5 million to $73.5 million for the first quarter of 2020, increased 19%, on a reported basis, and 9%, on an organic basis, compared to a year ago.Non-GAAP Adjusted EBITDA of $4.8 million, near the high end of our guidance range of $4.0 million to $5.0 million for the first quarter of 2020,... More